Arbutus Biopharma Corp
Arbutus Biopharma Corp (ABUS) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 41 transactions totaling $2.2M, demonstrating a bearish sentiment with -$2.2M in net insider flow. The most recent transaction on Feb 2, 2026 involved a transaction of 71,700 shares valued at $0.
ABUS Insider Activity Summary
Who Is Buying ABUS Stock?
No significant insider buying has been recorded for ABUS in the recent period.
Who Is Selling ABUS Stock?
No significant insider selling has been recorded for ABUS in the recent period.
Is Arbutus Biopharma Corp Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ABUS is bearish with an Insider Alignment Score of 0/100 and a net flow of -$2.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ABUS Frequently Asked Questions
Understanding ABUS Insider Activity
Insider trading at Arbutus Biopharma Corp (ABUS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading ABUS stock, having executed 41 transactions in the past 90 days. The most active insider is Michael J. Sofia (Executive), who has made 14 transactions totaling $1.8M.
Related Tools
Track Arbutus Biopharma Corp Insider Activity
Get notified when executives and directors at ABUS file new Form 4 transactions